75PCemiplimab, a human PD-1 monoclonal antibody, in patients (pts) with recurrent or metastatic cervical cancer: Interim data from phase I cohorts. (17th December 2018) - Rischin, D; Gil-Martin, M; González-Martin, A; Brana, I; Hou, J Y; Cho, D; Falchook, G; Formenti, S; Jabbour, S; Moore, K; Naing, A; Papadopoulos, K P; et al.